Discovery In Current And Former Smokers | Detection of NSCLC

NEWS & RESOURCES

Deep, Multiomics, Bloodbased Biomarker Discovery In Current And Former Smokers Demonstrated High Early Detection Performance For Nonsmall Cell Lung Cancer

This poster presented at the 2023 IASLC World Conference on Lung Cancer featured PrognomiQ’s multi-omics approach for the development of a statistical classifier for the detection of non-small cell lung cancer (NSCLC) in current and former smokers with high sensitivity and specificity, including Stage I cancers.

Download Poster scientific poster showing a deep, multiomics, blood-based biomarker discovery in current and former smokers demonstrated high early detection performance for non-small cell lung cancer